This week, the spotlight has turned to Casey Harrell, a groundbreaking figure in the realm of brain-computer interfaces (BCIs). Harrell, who lives with ALS, is the inaugural power user of a brain implant designed to enhance communication for individuals with severe disabilities. For nearly three years, he has utilized this innovative BCI, which allows him to express himself, browse the internet, and continue his work as a climate activist with increased independence. Since his device’s implantation at the University of California, Davis, researchers have fine-tuned its capabilities, enhancing accuracy and introducing valuable features such as a privacy mode and a profanity filter, ensuring Harrell can communicate freely with his daughter.
BCIs vary significantly in design and functionality. Harrell’s device comprises electrodes embedded in the brain, capturing neural activity linked to speech, which is then decoded by software into phonemes. This advanced technology allows him to make adjustments using an eye tracker before his speech is voiced aloud. While some BCIs require physical connections to a computer, others are fully wireless or less invasive, utilizing surface-mounted electrodes or even caps. While the closer proximity to neurons yields better signals, increased invasiveness can raise the risk of complications. Currently, most BCI users are individuals with spinal cord injuries, who may retain facial movement but encounter challenges with mobility. Recent studies show a significant uptick in BCI trials, with researchers identifying a growing number of volunteers eager to contribute to this innovative field.
The past couple of years have seen a surge in BCI development, with notable advancements in technology. For instance, Neuralink, co-founded by Elon Musk, has successfully implanted devices in multiple patients, while other companies, such as Synchron and Neuracle, are conducting trials across various locations. Academic contributions continue to flourish, with teams like BrainGate, which has operated for two decades, exploring both invasive and minimally invasive options. As more individuals participate in these trials, the understanding of BCIs will deepen, especially concerning their efficacy for ALS patients. Although promising, these devices remain experimental, and ongoing research is crucial to uncover their long-term viability and potential benefits for a wider audience. The future of BCIs holds great promise, and continued engagement from volunteers like Harrell is vital for advancing this transformative technology.
Source: Brain-computer interface trials are taking off via MIT Technology Review